Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

107 results about "Supplemental oxygen" patented technology

Supplemental oxygen is a physician-ordered therapy to provide your body with extra oxygen to support vital bodily functions in the presence of heart or lung disease.

Carbon dioxide nanosensor, and respiratory CO2 monitors

An electronic system and method for detecting analytes, such as carbon dioxide, is provided, using an improved nanostructure sensor (CO2 sensor). The CO2 sensor may comprise a substrate and a nanostructure, such as a one or more carbon nanotubes disposed over the substrate (e.g., as a network). One or more conductive elements may electrically communicate with the nanostructure. A counter or gate electrode may be positioned adjacent the nanostructure. A functionalization material reactive with carbon dioxide may be included, either disposed in contact with the nanostructure or isolated by a dielectric. The sensor may be connected to a circuit responsive to changes in CO2 concentration in the environment. Embodiments are described of medical sensing systems including one or more CO2 sensors. One embodiment comprises a breath sampling cannula which is connected to a sensor unit. In an alternative, the cannula permits supplemental oxygen to be administered, while recovering and measuring analytes in breath samples. The cannula may connect to a portable processor-display unit for monitoring one or more analytes, such as CO2. Another embodiment includes a cannula configured for the monitoring of sleep disorders, such as apnea, comprising one or more sensors disposed adjacent a breath sampling channel, optionally including flow rate or other sensors. The sensors may be connected by wired or wireless links for to a processor/input/display unit. Any of the embodiments may include filters, selectively permeable membranes, absorbents, and the like to precondition the breath sample, may be configured to include complementary chemistry measurements.
Owner:NANOMIX

Device and method for automatically regulating supplemental oxygen flow-rate

InactiveUS20060225737A1Minimize biasPrevent adverse eventsRespiratorsElectrocardiographySupplemental oxygen therapyClosed loop
Device and method for limiting adverse events during supplemental oxygen therapy are disclosed. In the present invention, the oxygen flow between a patient and an oxygen source is controlled with a valve such as a proportional solenoid capable of constraining flow-rates within a continuous range. The flow-rate of oxygen is accurately controlled in a closed-loop with flow-rate measurements. Measures of a patient's vital physiological statistics are used to automatically determine optimum therapeutic oxygen flow-rate. Controller signal filtering is disclosed to improve the overall response and stability. The control algorithm varies flow-rates to minimize disturbances in the patient feedback measurements.
Owner:IOBBI MR MARIO

Production enhancement for a reactor

This invention is directed to a process for increasing production of product that is formed in a reactor having a combustion section in which fuel is burned to produce heat to drive an endothermic reaction occurring within a reaction section. Production is increased by adding supplemental oxygen to air or other oxygen containing gas used to support combustion in the combustion section, thereby to generate more heat to support an increase in the endothermic reaction. Additionally, supplemental oxygen can be introduced into the reaction section to partially oxidize a reactant to generate heat and to allow an increase in the production of the product. Supplemental oxygen may be added directly to the steam-methane mixture, or to the combustion air.
Owner:PRAXAIR TECH INC

Method for realizing increase production of butadiene

The invention relates to a method for realizing the increase production of butadiene, which mainly solves the problem that the yield of the butadiene is not high because the conversion rates of 1-butene, cis-2-butene and reverse 2-butene as three isomers in the n-butene are different under the condition of utilizing the same catalyst in the prior art. According to the method, two segments of adiabatic and isothermal fixed bed reactors connected in series are adopted; butene, oxygen-containing gas and water vapor as raw materials enter the first segment of the reactor A filled with a catalyst I according to definite proportion; and after a heat exchange treatment is carried out on the gas at an outlet of the first segment of the reactor A, the gas is mixed with the supplemental oxygen-containing gas, and then mixed gas enters the second segment of the reactor B filled with a catalyst II according to definite proportion. Therefore, based on the technical scheme that the the catalyst I has high conversion rate for the 1-butene and the cis-2-butene and the catalyst II has high conversion rate for the reverse 2-butene, the problem is solved well. As a result, the method provided by the invention can be used for the industrial production of the butadiene by the oxidative dehydrogenation of the n-butene.
Owner:CHINA PETROLEUM & CHEM CORP +1

Reduced cognitive function detection and alleviation system for a pilot

ActiveUS20150196245A1Decline of cognitive functionAlleviate reduced cognitive function symptomOperating means/releasing devices for valvesRespiratory masksEngineeringSupplemental oxygen
A system for detecting and alleviating pilot hypoxia is provided. The system comprises an oxygen generator adapted to be powered by a power supply. The oxygen generator is in communication an oxygen delivery device where the oxygen delivery device is adapted to deliver supplemental oxygen to a pilot. A control module is in communication with the oxygen generator and the power supply. A hypoxia detection device is in communication with the control module wherein the control module causes one or both of the oxygen generator and the oxygen delivery device to increase an amount of oxygen being delivered to the pilot upon detection of pilot hypoxia. The hypoxia detection device may be comprised of a pupillometer and a luminometer and / or a flash generator.
Owner:COBHAM MISSION SYST DAVENPORT LSS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products